About Hydroxymethylglutaryl-CoA lyase, mitochondrial
Hydroxymethylglutaryl-CoA lyase, mitochondrial (HMGCL) is a protein
from Homo sapiens identified by UniProt accession
P35914, 325 residues long.
MolForge cross-references it against 0 known binders and
86 disease associations.
Target properties
| Protein name | Hydroxymethylglutaryl-CoA lyase, mitochondrial |
| UniProt accession | P35914 |
| Gene | HMGCL |
| Organism | Homo sapiens |
| Length | 325 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (86)
Diseases linked to this target (Open Targets).
- 3-hydroxy-3-methylglutaric aciduria · score 0.84
- long chain 3-hydroxyacyl-CoA dehydrogenase deficiency · score 0.52
- genetic disorder · score 0.49
- Intellectual disability · score 0.37
- reticulocyte count · score 0.27
- neurodegenerative disease · score 0.21
- erythrocyte count · score 0.14
- mean corpuscular hemoglobin · score 0.11
- red blood cell density measurement · score 0.10
- hepatocellular carcinoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P35914-F1 | alphafold | PREDICTED | 91.98 | — |
Amino-acid sequence (325 residues)
MAAMRKALPR RLVGLASLRA VSTSSMGTLP KRVKIVEVGP RDGLQNEKNI VSTPVKIKLI DMLSEAGLSV IETTSFVSPK WVPQMGDHTE VLKGIQKFPG INYPVLTPNL KGFEAAVAAG AKEVVIFGAA SELFTKKNIN CSIEESFQRF DAILKAAQSA NISVRGYVSC ALGCPYEGKI SPAKVAEVTK KFYSMGCYEI SLGDTIGVGT PGIMKDMLSA VMQEVPLAAL AVHCHDTYGQ ALANTLMALQ MGVSVVDSSV AGLGGCPYAQ GASGNLATED LVYMLEGLGI HTGVNLQKLL EAGNFICQAL NRKTSSKVAQ ATCKL
Explore Hydroxymethylglutaryl-CoA lyase, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets